Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 90 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1862. Clear
Clear
Q2
TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TIBER CREEK GROUP for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for EMD SERONO, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ASTRAZENECA
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $90,000.00 income
Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for AMGEN
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for JOHNSON & JOHNSON SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Bankruptcy
View →
Q2
THE NICKLES GROUP, LLC for MERCK & CO. INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View →
Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for UCB, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Georgia · House · Senate · $60,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View →
Previous Page 4 of 4

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem